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This review describes some of the most
important new or reemerging infectious diseases
in the United Kingdom in the past decade. Most
of the statistics relate to England and Wales,
where the surveillance system is operated by the
Public Health Laboratory Service (PHLS),
through its Communicable Disease Surveillance
Centre (CDSC). The statistics come from three
main sources and several more specialized ones.
The most important is the laboratory-based
surveillance system, started more than 50 years
ago, to which the national network of 48 public
health laboratories and the specialized reference
microbiology laboratories of PHLS and more
than 150 National Health Service laboratories
contribute regularly. Most data collection is
performed electronically, through a computer-
ized system that allows laboratory data to be
captured at the source, augmented with clinical
or risk factor data, and transmitted both
centrally to CDSC and locally to the responsible
public health professionals. CDSC also runs, on
behalf of the Office of National Statistics, the
long-established statutory notification system,
which is based on clinical reporting of a schedule
of infectious and communicable diseases includ-
ing food poisoning. The third system is a sentinel
system based on general practice run by the
Royal College of General Practitioners Research
Unit. These three systems complement each
other, and the data are collated, analyzed, and
disseminated by CDSC and are then extensively
used to inform both government policies and
local activities for the prevention and control of
communicable disease.
In addition to the big three, the United
Kingdom has several other more specific
surveillance systems, in particular, confidential
clinical reporting systems for AIDS and sexually
transmitted diseases and serosurveillance (in-
cluding unlinked anonymous) systems for HIV
infection. In addition, active surveillance
systems, developed jointly by PHLS and the
relevant professional associations, capture
clinical case reports of rare diseases, such as
pediatric AIDS and Reye syndrome. These active
systems are particularly suited to the surveil-
lance of rare and emerging diseases, such as
pediatric Creutzfeldt-Jakob (CJD) disease.
A growing number of disease-specific
surveillance systems, operated on a Europe-wide
basis, are increasingly attracting other interna-
tional participants. CDSC coordinates Enter-
Net, a Europe-wide scheme for surveillance of
salmonella and Escherichia coli O157. This
network, which comprises epidemiologists and
reference microbiologists from each member
state of the European Union plus Switzerland
and Norway, has led to the successful detection
and investigation of several international
foodborne outbreaks. A similar network coordi-
nated by CDSC exists for travel-associated
Legionnaires disease. A mainly European-based
surveillance network for meningococcal disease
is also working well.
One of the side-effects of an efficient
surveillance system is that because new diseases
or variants of diseases and outbreaks are
detected earlier than in countries with less
comprehensive systems, such diseases are often
thought to have originated, or to predominate, in
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that country. This happened, for example, with
Salmonella Enteritidis contamination of hens
eggs, which was, as it later became apparent, not
confined to the United Kingdom but was
widespread throughout Europe. However, one
emerging disease that did have its origins in the
United Kingdom is new variant (nv) CJD.
NvCJD
A previously undescribed encephalopathy in
cows, bovine spongiform encephalopathy, with
characteristic clinical and histologic features,
was first identified in November 1986, although
the first case may have occurred as early as April
1985. Since then, the number of cases reported in
the United Kingdom has exceeded 166,000.
However, the epidemic reached a peak in
1992-93. The number of cases recorded has been
diminishing since, and the cattle epidemic,
linked to the consumption of contaminated
ruminant-derived meat and bone meal, is
predicted to be over by 2001 (1). (The method of
rendering protein changed shortly before the
disease first appeared in cows.) Surveillance of
CJD in humans began in 1990, when the National
CJD Surveillance Unit was established in
Edinburgh, Scotland.
The first human cases of nvCJD appeared in
1995, with onset dates from February 1994 (2)
(Table). NvCJD was distinguished from classic
CJD on clinical and histologic grounds and by the
patients young age. Although evidence is
mounting that nvCJD is the human form of
bovine spongiform encephalopathy (3,4), no
direct association has yet been established
between the development of nvCJD and the
consumption of beef.
HIV/AIDS
An estimated 25,000 persons in the United
Kingdom are infected with HIV, an overall
prevalence of approximately 45 per 100,000
population (5). At least 15,000 are receiving care.
Disease prevalence varies considerably by
geographic area, with most cases in London and
the southeast of England. National prevalence is
lower than in all but four countries of Western
Europe. As in most countries of Northern
Europe, sex between mens remains the
predominant mode of HIV transmission. In the
United Kingdom, heterosexually acquired cases
are the second largest risk group. Most such
infections are in persons from, or who have lived
in, sub-Saharan Africa. Some heterosexually
acquired cases originate in other higher
prevalence areas of the world, as well as from
within the United Kingdom, but numbers are
currently fairly small. Apart from cities in
Scotland, where outbreaks occurred in the mid-
1980s, continuing HIV transmission among
injecting drug users appears low. Needle
exchange programs, which have contributed to
limiting spread, have been in place in most urban
areas of the United Kingdom since the late
1980s. In this country, HIV infection in pregnant
women is still not adequately recognized, and
thus steps to greatly reduce the chance of
transmission of infection from mother to baby
have not yet been taken. Recent guidance from
the Department of Health concerning the need
for HIV screening in pregnancy is intended to
address this problem.
In spite of considerable efforts to reduce the
spread of HIV in the United Kingdom, the
number of newly diagnosed cases of HIV
infection has been fairly constant in the 1990s.
The rates among male homosexual attendees
younger than 25 years of age at sexually
transmitted disease clinics have shown no signs
of decreasing, suggesting continued appreciable
HIV incidence in men who have sex with men.
Furthermore, the rates of acute sexually
transmitted infections (markers of unsafe sex) in
homosexual men have increased again after a
decline in the mid-1980s.
The incidence of AIDS (but not the incidence
of HIV infections) and the number of deaths have
fallen dramatically in the last 2 years as a result
of the introduction of highly active antiretroviral
therapies. This decrease has been most marked
in men who have acquired HIV through sex with
Table. Deaths of definite and probable U.K. cases due to
spongiform encephalopathy referred to the National
Creutzfeldt-Jakob Disease Surveillance Unita, 1995-1998b
Deaths of definite and probable cases
Refer- Spora-Iatro- Fami- nv-
Year rals dic genic lial GSSc CJDc Total
1995   87 35 4 2 3   3 47
1996 134 41 4 2 4 10 61
1997 161 58 6 4 1 10 79
1998 150 39 3 2 0 12 56
aData source: National CJD Surveillance Unit (set up in May
1990 by the Department of Health and the Scottish Office
Home and Health Department).
bTo Dec. 31, 1998 (provisional); total number of definite and
probable cases of nvCJD=35.
cGSS, Gerstmann-Straussler-Scheinker syndrome; nvCJD,
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men. A consequence of the falling death rate,
with sustained rates of new diagnoses, is
increasing prevalence of HIV infection.
Tuberculosis
After many years, tuberculosis is reemerging
in this country as in many other countries of the
world (6). In England and Wales the annual
number of cases had been declining for over 150
years, reaching its lowest point of 5,085 reported
cases (10.1 per 100,000 population) in 1987.
Since then, the number of cases has remained at
a plateau of 5,000 to 6,000 cases per year.
However, increases were recorded in 3 recent
consecutive years, 1995-1997. Moreover, within
these bare statistics, there are some disturbing
trends. Rates in certain ethnic groups have
increased significantly, while those in Cauca-
sians have continued to fall. Cases of
tuberculosis in persons of black African origin
accounted for 1% of all cases in 1988, and account
for more than 10% now. Multidrug-resistant
tuberculosis remains at a low level, although
nosocomial transmission has been reported. An
enhanced surveillance system and new technol-
ogy for rapid resistance testing have been put in
place.
E. coli O157
Extremely rare a decade ago, E. coli O157
infection is emerging as an important public
health problem in the United Kingdom because
of the severity of the illness it causes, even
though the annual number of reported infections
remains comparatively low (approximately
1,000). Undoubtedly the most important out-
break of E. coli O157 in the United Kingdom
originated in a butchers shop in Lanarkshire,
Scotland, in November and December 1996 (7).
Approximately 85 outlets in central Scotland
stocked the butchers products, which made the
task of outbreak management and control
extremely difficult. The date of onset of the first
known case was November 15 and of the last
confirmed case December 15. The number of
cases escalated rapidly from November 15 and at
the peak of the outbreak, November 25, reached
more than 40 cases (Figure 1) in 1 day; 496
persons were affected, and 18 persons died. One
of the features of the outbreak was the
occurrence of several separate incidents, the
largest of which was a birthday party for 100
persons in a church hall. All isolates of E. coli
O157 belonged to phage type 25 and contained
the verocytotoxin gene VT2. Pulsed-field gel
electrophoresis showed that all 262 strains
tested were indistinguishable. A group was
convened by the Scottish Office to consider the
circumstances that led to the outbreak and the
implications for food safety. Among the many
recommendations was the accelerated introduc-
tion of the Hazard Analysis/Critical Control
Point (HACCP) system (8) for high-risk premises
and the selective licensing of food premises.
Salmonella Food Poisoning and Other
Gastrointestinal Infections
Although hardly an emerging disease,
salmonella food poisoning has reemerged both in
incidence and in importance in recent years
(Figure 2). Much of this increase is attributable
to  S.  Enteritidis, which has accounted for
approximately 70% of all salmonella infections in
recent years, with S. Enteritidis phage type 4
accounting for 45% of the total. These strains are
closely associated with eggs and poultry. In
addition, multidrug-resistant S. Typhimurium
Figure 1. Escherichia coli O157 central Scotland
outbreak epidemic curve by date of onset of diarrhea.
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DT 104 has emerged as an important cause of
food-poisoning outbreaks. In 1997, the highest
number of salmonella infections was recorded
(32,596), but in 1998 only 23,216 cases
(provisional) were reported, a fall of about 30%.
It is too soon to say if this decrease will be
sustained and if it can be attributed to control
measures.  Campylobacter infections are the
major cause of laboratory-confirmed bacterial
gastrointestinal infections, while small-round
structured viruses now account for more than
40% of reported pathogens associated with
general outbreaks of infectious intestinal disease
in England and Wales (9).
Cryptosporidiosis
Cryptosporidium has emerged as a cause of
waterborne outbreaks since the 1980s. The
problem was considered serious enough for the
government to convene an expert group, which
reported in 1990. An outbreak in the north
Thames area of England in 1997 had 345
confirmed cases and probably many others, and
746,000 persons were advised to boil water
before consumption (10). This outbreak resulted
from contamination of a filtered borehole-
derived public water supply. A period of heavy
rainfall following the driest spell for at least 200
years may have contributed. Cryptosporidial
oocysts need to be filtered out of water as they are
not affected by normal concentrations of
chlorine, and the oocyst load was probably too
great for the filters at various times during this
unusual weather spell. This was the first
reported cryptosporidiosis outbreak in the
United Kingdom caused by filtered borehole
water and the third involving groundwater
supplies. It also resulted in the reconvening of
the expert group by the government. Mandatory
continuous sampling for Cryptosporidium in
supplies at risk is under consideration (11).
In an important advance, PHLS researchers
have recently demonstrated the existence of at
least two genotypes of C. parvum. Evidence so
far (12) suggests that whereas human infections
are associated with both genotypes, livestock
animal infections are associated with one
genotype only. If confirmed, these preliminary
findings should make an important contribution
to elucidating the epidemiology of this still-
emerging infection.
Meningococcal Disease
Meningococcal infection has produced a
sustained and somewhat baffling rise in
incidence in the 1990s (Figure 3), with an even
greater-than-expected increase in the first few
weeks of 1999. Although serogroup B disease
continues to predominate, the epidemiology is
changing; the proportion of infections caused by
serogroup C is increasing, and these infections
show an increasing tendency to cause clusters
and outbreaks in teenagers and young adults.
Conjugated vaccines against serogroup C are
under evaluation in the United Kingdom by
PHLS and others.
Chlamydia trachomatis
In recent years, the public health importance
of C. trachomatis infection has been increasingly
recognized. Reported rates of infection exceed
100 per 1,000,000 population in those ages 15 to
59 years, making it the most common bacterial
cause of sexually transmitted disease. It is
estimated that only 10% of cases are identified.
Chlamydia is an important cause of pelvic
inflammatory disease and infertility in un-
treated women. Targeted screening in groups at
high risk is under consideration.
Syphilis
On average, 3,000 new cases and 1,000 late
cases of syphilis are reported each year in
England and Wales. Approximately half of the
laboratory-confirmed cases appear to be indig-
enous infections; the remainder are acquired
abroad (13). A recent increase in infections
contracted in Russia has been noted. However, a
large, prolonged outbreak of indigenous syphilis
Figure 3. Meningococcal disease, 19941998 (5-week
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occurred in Bristol in England between January
1997 and May 1998. Forty-five persons were
infectedthe expected number was one or two
cases only. This was a heterosexually transmit-
ted outbreak, and, unusually, women outnum-
bered men by 26 to 19. An urgent coordinated
public health response identified many cases,
but a number of sexual contacts were
untraceable, and the potential for ongoing
transmission remains (14).
Diphtheria
Very few confirmed cases of infection with
toxigenic  Corynebacterium diphtheriae are
reported in the United Kingdom associated with
travel to disease-endemic areas. However, in
recent years, cases of nontoxigenic C. diphtheriae
var gravis have emerged. In the wider European
context, diphtheria has reemerged as a major
public health problem in the countries of the
former Soviet Union.
Antimicrobial Resistance
Levels of antimicrobial resistance, although
lower than in many other countries in Europe
and elsewhere, are an increasing cause for
concern. For example, the numbers and
geographic distribution of reported bloodstream
infections with methicillin-resistant Staphylo-
coccus aureus have escalated. Almost 32% of
staphylococcal septicemias in 1997 were caused
by methicillin-resistant S. aureus, compared
with only 2% in 1992. Antimicrobial resistance
has been the subject of two recent national
reports (15,16), and a comprehensive strategy is
being developed to address the problem (17).
Hepatitis C
For the community as a whole, hepatitis C is
a viral time-bomb which is slowly destroying the
health of large numbers of the world population
(18). In England and Wales, only 57% of reported
patients have known risk factors. Of these,
approximately 80% identified injecting drug use
as the main route of transmission, and 2.9%
reported sexual exposure. Blood or blood product
recipients accounted for 7.2% of the cohort of
cases diagnosed between 1992 and 1996; this
proportion is rapidly diminishing (19) as a result
of the screening of blood donors and the use of
treated blood products.
Influenza
Surveillance of influenza in England and
Wales has reached a high level of sophistication,
with many sources of data now available,
covering clinical reports, reports of deaths from
several different respiratory conditions, and
virus isolation and subtyping reports (20). In
1998, in the face of concern that influenza might
be reemerging because of the occurrence in Hong
Kong of 18 cases of infection (with 6 deaths) from
a new influenza subtype of avian origin,
A(H5N1), PHLS activated the first phase of its
pandemic influenza plan. The chicken-related
strain proved poorly transmissible to humans,
but the episode provided a useful practice run for
the contingency plan.
Measles
Given the existence of an effective vaccine
against measles, mumps, and rubella and a
comprehensive immunization program, there
might seem little prospect of measles emerging
once again as a serious public health problem in
the United Kingdom. However, vaccine coverage
has fallen recently, coinciding with adverse
publicity over an alleged link between the
vaccine and both Crohn disease and autism (21).
This illustrates the ever-present potential for
infections, even those close to elimination, to
regain the upper hand if preventive measures
are disrupted.
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